Finally, LSP1 expression in treatment-naïve tumor specimens from BrCa patients was largely restricted to the infiltrating leukocytes36,37 (Figures 2C and 2D) and high leukocyte-specific expression of LSP1 correlated with shorter progression-free survival in univariate analysis of BrCa (HR = 1.73, 95% CI 1.29–2.33; p = 0.01) (Figures 2E–2K; Table S18). The gene discussed is LSP1; the disease is invasive breast carcinoma.